{
  "ticker": "RAD",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02958876",
  "id": "02958876",
  "pages": 5,
  "price_sensitive": false,
  "date": "20250616",
  "time": "1656",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250616/pdf/06ksr1tr8ckg8w.pdf",
  "summary": "### **Substantial Holding Notice \u2013 Regal Funds Management in Radiopharm Theranostics Ltd (RAD)**  \n**Key Material Points:**  \n\n- **Change in Voting Power:**  \n  - Previous holding: **6.15%** (145,362,288 votes)  \n  - Current holding: **8.30%** (160,080,333 votes)  \n\n- **Details of Changes (Ordinary Shares):**  \n  - **Net Increase:** +14,718,045 shares (~2.15% dilution-adjusted increase).  \n  - Major transactions:  \n    - **Buy:** 40,000,000 shares @ $0.027 (31/03/2025).  \n    - **Sell:** Multiple disposals (e.g., 13,858,939 shares @ $0.023 on 3/04/2025).  \n\n- **Holding Dilution:**  \n  - **11/06/2025:** Holding diluted due to issuance of 30,969,360 new shares (exact impact already reflected in current %).  \n\n**ADS (American Depositary Shares) Details:**  \n- **Total ADS Holdings:** 90,909 ADS (1 ADS = 300 ordinary shares \u2192 **27,272,700 underlying shares**).  \n\n**Conclusion:**  \n- Regal Funds Management increased its stake by ~2.15%, primarily via large buys in Q1 2025, partially offset by smaller disposals.  \n- **Watch:** Potential liquidity impact from ADS conversions (27.3M shares) if unwound.  \n\n**Format Compliance:**  \n- Omitted non-material transactions (e.g., sub-1M share trades).  \n- Focused on net voting power change and largest trades.",
  "usage": {
    "prompt_tokens": 2483,
    "completion_tokens": 361,
    "total_tokens": 2844,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-16T07:26:13.093643"
}